Luye Pharma Group Ltd. (LYPHF) Financials
LYPHF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 5.1 billion | 2.5 billion |
| Dec. 31, 2025 | 4.7 billion | 2.0 billion |
| June 30, 2025 | 4.5 billion | 2.2 billion |
| Dec. 31, 2024 | 4.1 billion | 1.9 billion |
LYPHF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | ? | ? |
| Dec. 31, 2025 | 58.9 million | ? |
| June 30, 2025 | 249.1 million | 926424 |
| Dec. 31, 2024 | -157.0 million | 1.5 million |
LYPHF Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | ? |
| Dec. 31, 2025 | 43.0 million |
| June 30, 2025 | 43.7 million |
| Dec. 31, 2024 | 61.8 million |
LYPHF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 2.0 billion | 416.3 million | 2.5 million |
| Dec. 31, 2025 | 1.3 billion | 384.5 million | 10.0 million |
| June 30, 2025 | 1.2 billion | 434.4 million | 8.0 million |
| Dec. 31, 2024 | 890.9 million | 369.1 million | 8.5 million |
LYPHF Shares Outstanding
LYPHF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 37.3 million | 126.1 million | - |
| Dec. 31, 2025 | 9.1 million | 31.0 million | 167.4 million | 115.4 million |
| June 30, 2025 | 11.2 million | 27.0 million | 186.2 million | 142.2 million |
| Dec. 31, 2024 | 234.1 million | 29.8 million | 172.4 million | 132.3 million |
LYPHF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 435.8 million | 159.7 million |
| Dec. 31, 2025 | 439.6 million | 157.7 million |
| June 30, 2025 | 444.0 million | 142.9 million |
| Dec. 31, 2024 | 409.2 million | 139.9 million |
LYPHF
Price: $0.27
52 week price:
Earnings Per Share: 0.01 USD
P/E Ratio: 27
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.1 billion